Morris Scherlis, MD
Pain Medicine · Huntsville, ALNPI 1851380984
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Abbott at 46.9% of the total. Reporting peaked in 2023 at $144 and has fallen 62.6% since, to $54 in 2025. That places this record below the midpoint for pain medicine clinicians in AL, where the typical reported total is $1,761.
Across 27 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$247
- Almatica Pharma LLC$77
- AbbVie$74
- Medtronic$43
- Stryker$34
- Johnson & Johnson$16
- plus $37 from 3 others
What the payments were for
- Food & beverage$527100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 11 | $247 |
| Almatica Pharma LLC | 5 | $77 |
| AbbVie | 3 | $74 |
| Medtronic | 2 | $43 |
| Stryker | 2 | $34 |
| Johnson & Johnson | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
| Scilex Pharmaceuticals Inc. | 1 | $12 |
| AstraZeneca | 1 | $12 |
How this compares
$527 in reported general payments places this provider in the 30th percentile of 77 pain medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 3,272 | $54,626 |
| Xtampza ErOxycodone Myristate | 75 | $40,864 |
| Gabapentin | 1,416 | $19,888 |
| OxycontinOxycodone Hcl | 26 | $17,169 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 823 | $16,454 |
| Buprenorphine | 40 | $11,974 |
| Pregabalin | 372 | $10,181 |
| Hysingla ErHydrocodone Bitartrate | 13 | $8,492 |
| Fentanyl | 34 | $3,572 |
| Morphine Sulfate ErMorphine Sulfate | 125 | $3,297 |
| Methadone Hcl | 118 | $2,096 |
| Celecoxib | 28 | $2,059 |
| Oxycodone Hcl | 153 | $1,839 |
| Duloxetine Hcl | 136 | $1,520 |
| Cyclobenzaprine Hcl | 101 | $1,254 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Huntsville
- Michael CosgroveHuntsville$25K
- James ThackerHuntsville$13K
- John RobertsHuntsville$7K
- Thomas KrausHuntsville$2K
- Ronald CollinsHuntsville$837
- Roddie GanttHuntsville$539
- Christopher PaulBirmingham$64K
- Ron PitkanenMountain Brk$16K
- Elliott PenningtonDaphne$15K
- Grant StoneMobile$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.